The AllCells Blog

AllCells Blog

AllCells blog posts are dedicated to highlighting scientific trends, innovation, and technological advances within the biomedical industry. Data-driven studies and primary research are conducted to create our blogs and include experts within the following fields: immuno-oncologists, cell and gene therapy, academia, government, and contract research organizations.
Cell Therapy

Why You Should Start Clinical Grade Cell Supply Discussions Early in Cell and Gene Therapy Development

May 24, 2022

Why You Should Start Clinical Grade Cell Supply Discussions Early in Cell and Gene Therapy Development Cell and gene therapies represent an expanding category of transformative medicines with the potential […]

Dna Double Helix

What You Need to Know About Regenerative Medicine in 2022: Industry and Tech Trends

April 20, 2022

What You Need to Know About Regenerative Medicine in 2022: Industry and Tech Trends Growth in the Regenerative Medicine Field The regenerative medicine sector is on track for another watershed […]

AllCells Opens a New Collection Facility in Houston, Texas

March 29, 2022

AllCells Opens a New Collection Facility in Houston, Texas Expanding Its Donor Network AllCells, the leading provider of human hematological products and services, is pleased to announce the opening of […]

Donor Management Services

A Donor-Centric Approach to Cell and Gene Therapy

February 3, 2022

In the past decade, emerging therapeutic modalities like cell and gene therapies have opened up new treatment options for previously intractable diseases, changing the industry needs for primary tissues. While […]

*

AllCells Announces First to Market Launch of In Stock GMP-Compliant Cryopreserved Leukopaks

January 28, 2022

Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP-compliant Cryopreserved Leukopaks significantly decrease lead time AllCells, the industry leader in the […]

AllCells cryopreserved cells in vial

FAQ Series: The Science Behind Cryopreservation

January 11, 2022

Primary cells, such as those isolated from the bone marrow or peripheral blood, are important for a wide scope of research and clinical applications – from studying molecular mechanisms driving disease progression, to […]

AllCells GMP compliant Leukopak cells

GMP-Compliant Leukopaks for Allogeneic Cell Therapies

December 13, 2021

Adoptive cell therapies (ACTs), which is a treatment based on transferring cells (most often immune cells) into a patient, have revolutionized the standard of care to treat a broad range […]

AllCells GMP cryopreserved leukopak

GMP-Compliant Leukopaks Mitigate Risk in Cell and Gene Therapy Workflows

December 13, 2021

Isolated human primary cells are able to retain the morphological and functional characteristics of their tissue of origin, which makes them invaluable tools in life sciences to advance our understanding […]

AllCells' Cleanroom

AllCells Announces New GMP Cleanroom

December 13, 2021

Expansion of GMP capabilities to support the rapidly growing cell and gene therapy industry AllCells Alameda, CA Expands GMP Processing Capabilities AllCells, the industry leader in the procurement and customization […]

AllCells Bone Marrow

T Lymphocytes: A Look at their Role and Research Applications

September 15, 2021

T cells are the main effector cells of the adaptive immune system and can be distinguished from other white blood cells by the presence of a T-cell receptor (TCR) on […]

Subscribe to Our Blog

Stay current with the AllCells Blog. Get email updates with helpful resources for biomedical researchers:

Customer Service

How Can We Help You?


Looking for research tips? Need help sourcing materials? How about a few more articles on therapies or processes? At AllCells, we believe that partnerships create the best pathways to success. Our Customer Success Team has years of industry experience and a wealth of resources to help you get the most out of your cellular products. We’re only a few clicks away.

Contact Us
Have a question? Let’s chat.